ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SNG Synairgen Plc

4.52
-0.235 (-4.94%)
24 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.235 -4.94% 4.52 4.35 4.69 4.75 4.36 4.75 212,429 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.50 9.58M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.76p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.58 million. Synairgen has a price to earnings ratio (PE ratio) of -0.50.

Synairgen Share Discussion Threads

Showing 6501 to 6522 of 99175 messages
Chat Pages: Latest  271  270  269  268  267  266  265  264  263  262  261  260  Older
DateSubjectAuthorDiscuss
06/5/2020
12:05
Is it me or am I missing something? Aren't the tests in the hospital the same as the home ones, in which case when the hospital trial results are known earlier it will be the same for the home trials surely ?
paradise city
06/5/2020
12:02
I see that bioMérieux have now received FDA authorization for a new (version 2:1) respiratory panel for use with the biofire point of care film array. This new version can now detect COVID-19 along with 20 (plus) other respiratory tract pathogens:



Synairgen have been using the Biofire film array with a previous version of the Respiratory Panel (which did not include COVID-19) in the COPD study, so I suspect they will be using the 2.1 panel for the remaining patients in that study.

I wonder too whether this is the POC test Synairgen will be using for the second part (non-hospitalised patients) of the SNG001 COVID study?

timbo003
06/5/2020
12:01
I think your timings will prove to be out by a margin. Of course they are saying end of June to give them time but I expect the results will be towards the beginning of June. The home tests will take a couple of months with results around end of summer. My reasoning is that we only needed around 20 more hospital patients a week ago and allowing for the 14 day treatment period should mean the trial ends around end May. It won’t take a month to analyse the results.
rafboy
06/5/2020
11:58
Thanks for making us all aware of your trading plans
We best all exit before you then
🤣😂

judijudi
06/5/2020
11:56
I have a largish position here. Assuming trial 1 completes successfully by end June, trial 2 would take to end 2020 at best even with fast-tracking by the authorities. so volume production hitting the users would not take place till end 2020 / Q1 2021.

And that bothers me. Competitors will not be standing still. So I am thinking of liquidating before end June, if the share price gets to 80+.

ramridge
06/5/2020
11:55
Buying seems relentless. Can’t be held back much longer by “ hidden “ sells. We’d be over a quid easy without the off load
peachie 74
06/5/2020
11:33
Posted that on ncyt minutes ago, must be doing the rounds
bobaxe1
06/5/2020
10:54
also ncyt
moving up
some after all the large buys there in recent days
sng holding not to bad
some selling and taking profits
other seeing the sellers as an opportunity to buy in lower

bunz3
06/5/2020
10:48
Toffee - Link have not sold a bean yet? Agreed it’s surprising
talk2dubya
06/5/2020
10:23
be finished tomorrow , onwards and upwards

zorro

d1nga
06/5/2020
10:21
How many to go I thought we were nearly finished
bobaxe1
06/5/2020
10:21
Please all sell your shares so I can buy your shares cheap before the next bounce.
svenice7
06/5/2020
10:13
Link has 17m shares to shift - I think we call it an overhang.

That is what drove the price down to 6p and will keep the price down until they are done selling.

Lansdowne will also be a seller - I don't suppse they want to keep their current large holding.

toffeeman
06/5/2020
10:10
I will be a buyer if it bounces around 50p or thereabouts. Would be a triple bottom
volsung
06/5/2020
10:07
If seller is also a buyer, that may explain why no more TR1s?
wetdream
06/5/2020
09:54
MM could have been sat on millions for weeks now from II, with the task of each day feeding them to the public..it has to end at some point..
peachie 74
06/5/2020
09:27
Seller and MM in league they have a don’t sell below 50p agreement. Then MM free to make a killing.
dealer55
06/5/2020
09:04
Yes, TR-1s could land and boost (or knock back) the share price at any time.
801710245
06/5/2020
09:01
I saw someone post on LSE the other day that there will be no news between now and end of June.

I think that is wrong, how can there not be any majors sniffing round this at the moment. That million buy is interesting.

talk2dubya
06/5/2020
09:00
POO- What has the 'Price Of Oil' got to do with a pharma?
bmnsa
06/5/2020
08:59
Perhaps someone with money’s p!ssed off with the daily downward trend?!
Another couple of those and we’ll be up and away. :-))

wetdream
06/5/2020
08:59
Nearly 2 mill traded, share price dives I wonder what’s going on, supply tap still active
crookie3634
Chat Pages: Latest  271  270  269  268  267  266  265  264  263  262  261  260  Older